Reflect Scientific, Inc. - Understand $rscf stock

$RSCF Market Cap: $3.698 Million

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$1.722M

TTM

Gross Margin

55.62%

TTM

Net Earnings

-$29.42K

TTM

Current Assets

$2.093M

Q3 2024

Current Liabilities

$139.3K

Q3 2024

Current Ratio

1503.28%

Q3 2024

Total Assets

$2.338M

Q3 2024

Total Liabilities

$258.5K

Q3 2024

Book Value

$2.080M

Q3 2024

Cash

$1.030M

Q3 2024

P/E

-125.7

Nov 27, 2024 EST

Free Cash Flow

Revenues

Revenue YoY Change

Revenues

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006
Revenue	$1.080M	$2.041M	$2.815M	$2.793M	$1.609M	$1.552M	$1.066M	$1.189M	$1.037M	$1.528M	$1.290M	$1.330M	$1.990M	$2.400M	$3.380M	$10.13M	$8.020M	$2.570M
YoY Change	-47.09%	-27.48%	0.79%	73.54%	3.69%	45.62%	-10.33%	14.58%	-32.11%	18.44%	-3.01%	-33.17%	-17.08%	-28.99%	-66.63%	26.31%	212.06%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006
Revenue	$1.080M	$2.041M	$2.815M	$2.793M	$1.609M	$1.552M	$1.066M	$1.189M	$1.037M	$1.528M	$1.290M	$1.330M	$1.990M	$2.400M	$3.380M	$10.13M	$8.020M	$2.570M
Cost Of Revenue	$483.7K	$822.1K	$884.1K	$1.071M	$617.6K	$487.2K	$405.9K	$376.1K	$407.1K	$678.3K	$620.0K	$620.0K	$990.0K	$1.310M	$1.950M	$5.500M	$4.630M	$1.520M
Gross Profit	$596.4K	$1.219M	$1.931M	$1.721M	$991.6K	$1.065M	$659.8K	$812.6K	$630.2K	$849.6K	$670.0K	$710.0K	$1.000M	$1.090M	$1.440M	$4.630M	$3.390M	$1.050M
Gross Profit Margin	55.22%	59.72%	68.59%	61.64%	61.62%	68.61%	61.91%	68.36%	60.75%	55.61%	51.94%	53.38%	50.25%	45.42%	42.6%	45.71%	42.27%	40.86%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006
Selling, General & Admin	$1.034M	$1.056M	$1.044M	$885.0K	$976.5K	$1.210M	$1.015M	$993.4K	$1.017M	$1.546M	$1.320M	$1.090M	$1.560M	$1.170M	$3.000M	$4.860M	$8.800M	$2.180M
YoY Change	-2.03%	1.07%	18.02%	-9.37%	-19.28%	19.13%	2.21%	-2.35%	-34.2%	17.13%	21.1%	-30.13%	33.33%	-61.0%	-38.27%	-44.77%	303.67%
% of Gross Profit	173.39%	86.59%	54.1%	51.41%	98.47%	113.6%	153.88%	122.25%	161.42%	181.97%	197.01%	153.52%	156.0%	107.34%	208.33%	104.97%	259.59%	207.62%
Research & Development	$29.54K	$73.43K	$58.34K	$185.3K	$210.0K	$104.1K	$46.70K	$70.80K	$72.86K	$22.14K	$40.00K	$40.00K	$30.00K	$10.00K	$20.00K	$300.0K
YoY Change	-59.77%	25.86%	-68.52%	-11.77%	101.84%	122.81%	-34.04%	-2.83%	229.09%	-44.65%	0.0%	33.33%	200.0%	-50.0%	-93.33%
% of Gross Profit	4.95%	6.02%	3.02%	10.76%	21.18%	9.77%	7.08%	8.71%	11.56%	2.61%	5.97%	5.63%	3.0%	0.92%	1.39%	6.48%
Depreciation & Amortization			$0.00	$3.786K	$3.980K	$2.980K	$0.00	$5.320K	$28.73K	$39.14K	$50.00K	$290.0K	$330.0K	$340.0K	$550.0K	$1.730M	$1.060M	$130.0K
YoY Change			-100.0%	-4.87%	33.56%		-100.0%	-81.48%	-26.6%	-21.72%	-82.76%	-12.12%	-2.94%	-38.18%	-68.21%	63.21%	715.38%
% of Gross Profit			0.0%	0.22%	0.4%	0.28%	0.0%	0.65%	4.56%	4.61%	7.46%	40.85%	33.0%	31.19%	38.19%	37.37%	31.27%	12.38%
Operating Expenses	$1.064M	$1.129M	$1.103M	$1.070M	$1.186M	$1.314M	$1.062M	$1.064M	$1.090M	$1.568M	$1.350M	$1.120M	$1.600M	$1.180M	$3.020M	$5.160M	$8.800M	$2.180M
YoY Change	-5.79%	2.38%	3.04%	-9.79%	-9.68%	23.69%	-0.2%	-2.39%	-30.48%	16.16%	20.54%	-30.0%	35.59%	-60.93%	-41.47%	-41.36%	303.67%
Operating Profit	-$467.3K	$90.10K	$827.8K	$651.0K	-$194.8K	-$248.9K	-$402.2K	-$251.6K	-$460.0K	-$718.6K	-$680.0K	-$410.0K	-$600.0K	-$90.00K	-$1.580M	-$530.0K	-$5.410M	-$1.130M
YoY Change	-618.64%	-89.12%	27.16%	-434.14%	-21.71%	-38.12%	59.85%	-45.3%	-35.99%	5.68%	65.85%	-31.67%	566.67%	-94.3%	198.11%	-90.2%	378.76%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2023	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006
Interest Expense			$890.00	-$760.00	-$660.00	$0.00	-$310.00	-$59.49K	-$123.2K	-$120.0K	-$320.0K	-$530.0K	-$540.0K	-$1.010M	-$1.600M	-$1.410M	$0.00
YoY Change			-217.11%	15.15%		-100.0%	-99.48%	-51.71%	2.66%	-62.5%	-39.62%	-1.85%	-46.53%	-36.88%	13.48%
% of Operating Profit			0.14%
Other Income/Expense, Net	$8.560K	$0.00	$10.00K			$0.00	$35.72K	$0.00	$3.550K	$0.00	$0.00	$0.00	$0.00	$0.00	$10.00K	$20.00K	$20.00K
YoY Change		-100.0%				-100.0%		-100.0%						-100.0%	-50.0%	0.0%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006
Pretax Income	-$458.7K	$90.10K	$939.1K	$660.1K	-$195.6K	-$249.5K	-$402.2K	-$216.2K	$835.9K	-$840.8K	-$1.010M	$200.0K	-$1.190M	-$620.0K	-$4.000M	-$2.130M	-$6.800M	-$1.320M
YoY Change	-609.13%	-90.41%	42.26%	-437.5%	-21.61%	-37.96%	86.03%	-125.86%	-199.42%	-16.75%	-605.0%	-116.81%	91.94%	-84.5%	87.79%	-68.68%	415.15%
Income Tax	$310.00	$702.00			$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$40.00K	$280.0K	-$340.0K
% Of Pretax Income		0.78%							0.0%			0.0%
Net Earnings	-$459.0K	$89.40K	$939.1K	$660.1K	-$195.6K	-$249.5K	-$402.2K	-$216.2K	$835.9K	-$840.8K	-$1.010M	$200.0K	-$1.190M	-$1.770M	-$4.880M	-$2.160M	-$7.080M	-$980.0K
YoY Change	-613.48%	-90.48%	42.26%	-437.5%	-21.61%	-37.96%	86.03%	-125.86%	-199.42%	-16.75%	-605.0%	-116.81%	-32.77%	-63.73%	125.93%	-69.49%	622.45%
Net Earnings / Revenue	-42.5%	4.38%	33.36%	23.64%	-12.15%	-16.08%	-37.74%	-18.19%	80.59%	-55.03%	-78.29%	15.04%	-59.8%	-73.75%	-144.38%	-21.32%	-88.28%	-38.13%
Basic Earnings Per Share	-$0.01	$0.00	$0.01	$0.04
Diluted Earnings Per Share	-$0.01	$0.00	$0.01	$0.01	-$2.472K	-$3.343K	-$6.064K	-$3.434K	$14.36K	-$15.50K	-$0.02	$0.00	-$0.03	-$0.05	-$0.13	-$0.06	-$0.21	-$0.03

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
Cash & Short-Term Investments	$1.278M	$1.382M	$1.474M	$642.5K	$555.2K	$220.4K	$235.9K	$264.0K	$292.1K	$271.1K	$250.0K	$260.0K	$350.0K	$240.0K	$170.0K	$450.0K	$1.150M
YoY Change	-7.52%	-6.24%	129.39%	15.74%	151.85%	-6.54%	-10.65%	-9.63%	7.76%	8.42%	-3.85%	-25.71%	45.83%	41.18%	-62.22%	-60.87%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets	$11.72K	$20.22K	$31.31K	$24.13K	$27.48K	$3.510K	$3.100K	$3.100K	$3.100K	$3.100K	$0.00	$110.0K	$0.00	$10.00K	$80.00K	$870.0K	$170.0K
YoY Change	-42.04%	-35.42%	29.76%	-12.19%	682.91%	13.23%	0.0%	0.0%	0.0%		-100.0%		-100.0%	-87.5%	-90.8%	411.76%
Inventory	$972.3K	$797.4K	$624.5K	$438.6K	$252.9K	$142.3K	$155.4K	$227.0K	$206.4K	$216.0K	$310.0K	$370.0K	$390.0K	$380.0K	$590.0K	$770.0K	$730.0K
Prepaid Expenses
Receivables	$108.2K	$129.3K	$175.7K	$340.4K	$118.5K	$155.5K	$122.4K	$73.42K	$136.4K	$256.2K	$150.0K	$140.0K	$140.0K	$240.0K	$520.0K	$1.010M	$1.370M
Other Receivables	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$30.00K	$30.00K
Total Short-Term Assets	$2.370M	$2.329M	$2.305M	$1.446M	$954.0K	$521.8K	$516.8K	$567.5K	$638.0K	$746.3K	$720.0K	$870.0K	$890.0K	$870.0K	$1.360M	$3.120M	$3.450M
YoY Change	1.77%	1.02%	59.46%	51.55%	82.82%	0.98%	-8.94%	-11.05%	-14.51%	3.65%	-17.24%	-2.25%	2.3%	-36.03%	-56.41%	-9.57%
Property, Plant & Equipment	$235.7K	$54.27K	$110.5K	$167.6K	$61.74K	$7.770K	$0.00	$0.00	$0.00	$0.00	$0.00	$10.00K	$20.00K	$60.00K	$420.0K	$590.0K	$260.0K
YoY Change	334.22%	-50.88%	-34.1%	171.53%	694.59%						-100.0%	-50.0%	-66.67%	-85.71%	-28.81%	126.92%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$3.100K	$3.100K	$3.100K	$3.100K	$3.100K	$3.100K	$3.100K	$3.100K	$3.100K	$3.100K	$0.00	$0.00	$0.00	$0.00	-$10.00K	$60.00K	$260.0K
YoY Change	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%					-100.0%	-116.67%	-76.92%
Total Long-Term Assets	$298.8K	$117.4K	$173.6K	$230.7K	$124.8K	$70.86K	$63.10K	$63.10K	$68.41K	$97.14K	$140.0K	$450.0K	$3.230M	$3.680M	$4.790M	$6.120M	$6.370M
YoY Change	154.56%	-32.39%	-24.77%	84.84%	76.16%	12.3%	0.0%	-7.76%	-29.58%	-30.61%	-68.89%	-86.07%	-12.23%	-23.17%	-21.73%	-3.92%
Total Assets	$2.669M	$2.446M	$2.479M	$1.676M	$1.079M	$592.7K	$579.9K	$630.6K	$706.4K	$843.4K	$860.0K	$1.320M	$4.120M	$4.550M	$6.150M	$9.240M	$9.820M
YoY Change
Accounts Payable	$86.24K	$78.97K	$66.84K	$70.21K	$108.6K	$2.450K	$53.51K	$58.97K	$84.35K	$59.40K	$40.00K	$90.00K	$90.00K	$200.0K	$510.0K	$590.0K	$430.0K
YoY Change	9.21%	18.15%	-4.8%	-35.36%	4333.06%	-95.42%	-9.26%	-30.09%	42.0%	48.5%	-55.56%	0.0%	-55.0%	-60.78%	-13.56%	37.21%
Accrued Expenses	$62.68K	$57.39K	$56.45K	$58.68K	$46.32K				$0.00	$0.00	$550.0K	$430.0K	$1.330M	$810.0K	$360.0K	$120.0K	$180.0K
YoY Change	9.22%	1.67%	-3.8%	26.68%						-100.0%	27.91%	-67.67%	64.2%	125.0%	200.0%	-33.33%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00	$0.00	$8.740K	$59.88K	$0.00	$0.00	$9.400K	$20.28K	$110.0K	$110.0K	$130.0K	$150.0K	$160.0K	$140.0K	$150.0K
YoY Change				-100.0%	-85.4%			-100.0%	-53.65%	-81.56%	0.0%	-15.38%	-13.33%	-6.25%	14.29%	-6.67%
Long-Term Debt Due									$0.00	$0.00	$650.0K	$650.0K	$2.930M	$2.930M	$2.930M	$1.770M	$20.00K
YoY Change										-100.0%	0.0%	-77.82%	0.0%	0.0%	65.54%	8750.0%
Total Short-Term Liabilities	$596.4K	$149.6K	$241.9K	$242.6K	$513.2K	$74.93K	$124.4K	$59.07K	$151.7K	$1.410M	$1.360M	$1.290M	$4.480M	$4.100M	$3.980M	$2.850M	$920.0K
YoY Change	298.67%	-38.15%	-0.32%	-52.72%	584.91%	-39.78%	110.63%	-61.06%	-89.24%	3.67%	5.43%	-71.21%	9.27%	3.02%	39.65%	209.78%
Long-Term Debt	$0.00	$0.00	$0.00	$111.3K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$10.00K	$20.00K	$660.0K
YoY Change			-100.0%											-100.0%	-50.0%	-96.97%
Other Long-Term Liabilities	$180.0K	$0.00	$57.39K	$109.3K	$12.55K
YoY Change		-100.0%	-47.51%	771.24%
Total Long-Term Liabilities	$180.0K	$0.00	$57.39K	$220.7K	$12.55K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$10.00K	$20.00K	$660.0K
YoY Change		-100.0%	-73.99%	1658.41%										-100.0%	-50.0%	-96.97%
Total Liabilities	$776.3K	$149.6K	$299.2K	$463.3K	$525.8K	$74.93K	$124.4K	$59.07K	$151.7K	$1.410M	$1.360M	$1.290M	$4.480M	$4.100M	$3.990M	$2.870M	$1.580M
YoY Change	418.97%	-50.01%	-35.41%	-11.88%	601.65%	-39.78%	110.63%	-61.06%	-89.24%	3.67%	5.43%	-71.21%	9.27%	2.76%	39.02%	81.65%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022	2021
Basic Shares Outstanding	85.22M shares	84.99M shares	84.74M shares
Diluted Shares Outstanding	85.22M shares	85.44M shares	85.49M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Stock Price

Market Cap: $3.6977 Million

About REFLECT SCIENTIFIC, INC.

Reflect Scientific, Inc. engages in the business of manufacturing and distribution of innovative products targeted at the life sciences market. The company is headquartered in Orem, Utah and currently employs 7 full-time employees. The company went IPO on 2001-06-26. The Company’s product portfolio includes ultra-low temperature freezers, blast freezers, solvent chillers and refrigerated transportation in addition to supplying original equipment manufacturer (OEM) products to the life sciences industry. The firm's brand Cryometrix is an ultra-low temperature and blast freezer design that enables its customers to save substantially on energy costs related to cryogenic storage. The firm also offers Solvent chillers, which are used in natural product extraction for optimizing product yield and purity. Its products range from non-mechanical Cyrometrix freezers and value-added products and components for the life sciences industry to tools and analytical services for industrial manufacturing. Its customers include hospitals, diagnostic laboratories, pharmaceutical and biotech companies, cold chain management and others.

Industry: Laboratory Apparatus & Furniture Peers: APPLIED DNA SCIENCES INC Rivulet Media, Inc. PRESSURE BIOSCIENCES INC Telesis Bio Inc. ECO SCIENCE SOLUTIONS, INC. INTERNATIONAL ISOTOPES INC ATLANTIC INTERNATIONAL CORP. THERMO FISHER SCIENTIFIC INC.